Showing results (171-180 of 223) with videos related to

Sort By:
Pageof 23
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 5, 2019
Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working PartyAleksandar Radujkovic, Sascha Dietrich, Henric-Jan Blok, et al.
Bone Marrow Transplantation|May 10, 2023
An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMTMeral Beksac, Simona Iacobelli, Linda Koster, et al.
Bone Marrow Transplantation|April 7, 2021
Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMTMitja Nabergoj, Katya Mauff, Marie Robin, et al.
Leukemia & Lymphoma|August 9, 2020
Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphomaGraeme A M Fraser, Asher Chanan-Khan, Fatih Demirkan, et al.
Blood Advances|August 19, 2025
Association of PET4 Response With Outcomes of BV-CHP vs CHOP in the ECHELON-2 Trial in CD30+ Peripheral T-cell LymphomaSwaminathan P Iyer, Neha Mehta-Shah, Ranjana H Advani, et al.
Leukemia|July 10, 2024
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI TrialFabio Efficace, Francois-Xavier Mahon, Johan Richter, et al.
European Journal of Haematology|February 13, 2021
Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMTLaurent Garderet, Giulia Sbianchi, Simona Iacobelli, et al.
Blood|March 31, 2021
FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemiaVaclav Seda, Eva Vojackova, Laura Ondrisova, et al.
Leukemia|November 25, 2018
JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activationJulia Czech, Sabrina Cordua, Barbora Weinbergerova, et al.
The Lancet. Oncology|May 9, 2018
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trialSusanne Saussele, Johan Richter, Joelle Guilhot, et al.
Pageof 23